Home › NDC Lookup › RxCUI directory › RxCUI 2681044

100 ML edaravone 0.6 MG/ML Injection — RxCUI 2681044

RxNorm drug concept · Semantic clinical drug
RxCUI 2681044 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2681044
Official name100 ML edaravone 0.6 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asedaravone 60 MG per 100 ML Injection; edaravone 60 MG in 100 ML Injection
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Edaravone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Radicava is approved to treat ALS — amyotrophic lateral sclerosis, sometimes called Lou Gehrig's disease. It's a progressive disease that affects the nerve cells controlling your m...
  • Each infusion takes about 60 minutes and is given by a healthcare provider — you won't be doing this at home on your own. The schedule works in cycles: for your first cycle, you go...
  • How is the IV infusion given, and how often do I need to go in?
  • The most common side effects seen in studies include bruising, changes in your walking or balance, and headache. Skin reactions like rash or eczema can also happen. The ones to act...
📖 Read our full Edaravone Injection guide →

🕸️ Concept Web — How 100 ML edaravone 0.6 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 100 ML edaravone 0.6 MG/ML Injection RxCUI 2681044

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Edaravone 1921877
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Edaravone Injection 1921880
    • Edaravone Injectable Product 1921879
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Edaravone 0.6 MG/ML 2681043

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Edaravone 0.6 MG/ML SCDC · 2681043
  • Edaravone Injection SCDF · 1921880
  • Edaravone Injectable Product SCDG · 1921879

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2681044 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
39822-4510-01 1 VIAL, SINGLE-DOSE in 1 CARTON (39822-4510-1) / 100 mL in... edaravone XGen Pharmaceuticals DJB, Inc. 2024-12-02
68083-0500-02 2 POUCH in 1 CARTON (68083-500-02) / 1 BAG in 1 POUCH / 100... edaravone Gland Pharma Limited 2024-05-06
68083-0501-01 1 POUCH in 1 CARTON (68083-501-01) / 1 BAG in 1 POUCH / 100... edaravone Gland Pharma Limited 2024-05-06
Observed labelers: Gland Pharma Limited (2) · XGen Pharmaceuticals DJB, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.